EUVIMEDEUVIMED entdecken
Crossref

A Nanoplatform Based on Pillar[5]arene Nanovalves for Combined Drug Delivery and Enhanced Antitumor Activity

Jianfeng Jiang, Zhilian Su, Qin He, Wengui Duan, Yan Huang, Luzhi Liu iD

Chemistry – A European Journal · 2024

DOI: 10.1002/chem.202400007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2024. Verfasst von Jianfeng Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Colleges and Universities Key Laboratory of Applied Chemistry, Technology and Resource Development, School of Chemistry and Chemical Engineer…. Hauptthemen laut MEDLINE: Metal Nanoparticles, Antineoplastic Agents, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modern nanodrug delivery technologies offer new approaches in the fight against cancer. However, due to the heterogeneity of tumors and side effects of anticancer drugs, monotherapies are less effective. Herein, we report a novel pH and light dual‐responsive nanodrug delivery platform. The platform was formed by sulfonate‐modified gold nanoparticles loaded with the anticancer drugs doxorubicin (DOX) and glucose oxidase (GOx) and then covered by water‐soluble pillar[5]arene as a nanovalve. The nanovalve formed by the host‐guest interaction between pillar[5]arene and the sulfonic acid group grafted onto the gold nanoparticle increased the drug loading capacity of the nanoplatform and enabled sustained release of the drug in a simulated weakly acidic tumor environment. The released GOx can consume intracellular glucose, namely, starvation therapy, while the generated hydrogen peroxide can further kill tumor cells, complementing DOX chemotherapy. Gold nanoparticles have good photothermal conversion ability and can enhance the drugs release rate under specific wavelengths of light irradiation. The results of in vitro and in vivo experiments showed that this novel nanodrug delivery platform has good biocompatibility and better therapeutic efficacy relative to monotherapy. This study successfully developed a combined chemo/starvation therapy strategy with good tumor suppression, providing a new approach for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal NanoparticlesAntineoplastic AgentsNanoparticlesNeoplasmsHumansGoldPhototherapyDrug Delivery SystemsDoxorubicinDrug LiberationCell Line, Tumor

Stichwörter der Autor:innen

combined therapydrug deliverynanoparticlesnanovalvespillar[n]arene

Substanzen

GoldAntineoplastic AgentsDoxorubicin

Autor:innen und Institutionen

  • Guangxi Colleges and Universities Key Laboratory of Applied Chemistry, Technology and Resource Development, School of Chemistry and Chemical Engineering, Guangxi University, Nanning, 530004, China.
  • Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Chinese Traditional Medical & Pharmaceutical Science, Nanning, China.
  • Guangxi Key Lab of Agricultural Resources Chemistry and Biotechnology, College of Chemistry and Food Science, Yulin Normal University, Yulin, Guangxi, 537000, PR China.

ORCID-Profile: Luzhi Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Jiang, J., Su, Z., He, Q., Duan, W., Huang, Y., & Liu, L. (2024). A Nanoplatform Based on Pillar[5]arene Nanovalves for Combined Drug Delivery and Enhanced Antitumor Activity. Chemistry – A European Journal. https://doi.org/10.1002/chem.202400007

Vancouver

Jiang J, Su Z, He Q, Duan W, Huang Y, Liu L. A Nanoplatform Based on Pillar[5]arene Nanovalves for Combined Drug Delivery and Enhanced Antitumor Activity. Chemistry – A European Journal. 2024. doi:10.1002/chem.202400007

BibTeX
@article{Jiang2024,
  author = {Jiang, Jianfeng and Su, Zhilian and He, Qin and Duan, Wengui and Huang, Yan and Liu, Luzhi},
  title = {A Nanoplatform Based on Pillar[5]arene Nanovalves for Combined Drug Delivery and Enhanced Antitumor Activity},
  journal = {Chemistry – A European Journal},
  year = {2024},
  doi = {10.1002/chem.202400007}
}
Kostenlos starten →